Pulmocide is Drug Discovery in United Kingdom that focus on spare systemic exposure business. Founded in 2007. They cover business area such as developer, inhale therapy, acute and chronic respiratory disease, inhaled use, drug, spare systemic exposure, superior efficacy, respiratory aspergillosis, systemic toxicity, doctor, their patient.
2007
( 17 years old in 2024 )
Spare Systemic Exposure
-
44 Southampton Buildings
London WC2A 1AP
England, United Kingdom
Private
developerinhale therapyacute and chronic respiratory diseaseinhaled usedrugspare systemic exposuresuperior efficacyrespiratory aspergillosissystemic toxicitydoctortheir patient
* We use standard office opening hours in near Pulmocide's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Pulmocide is Drug Discovery business from United Kingdom that founded in 2007 (17 years old in 2024), Pulmocide business is focusing on Spare Systemic Exposure.
Pulmocide headquarter office and corporate office address is located in 44 Southampton Buildings London WC2A 1AP England, United Kingdom.
Pulmocide was founded in United Kingdom.
In 2024, Pulmocide is currently focus on spare systemic exposure sector.
Above is snippet of Google Trends for "spare systemic exposure" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Pulmocide, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
